{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T16:40:51Z","timestamp":1785516051080,"version":"3.56.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Peptides"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.peptides.2017.06.009","type":"journal-article","created":{"date-parts":[[2017,7,6]],"date-time":"2017-07-06T18:45:11Z","timestamp":1499366711000},"page":"40-50","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Characterization of CRF 1 receptor antagonists with differential peripheral vs central actions in CRF challenge in rats"],"prefix":"10.1016","volume":"95","author":[{"given":"Maiko","family":"Tanaka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiro","family":"Tomimatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuya","family":"Sakimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshikazu","family":"Ootani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuu","family":"Sako","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuto","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuyoshi","family":"Aso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiko","family":"Yano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Hirai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.peptides.2017.06.009_bib0005","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1126\/science.6267699","article-title":"Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin","volume":"213","author":"Vale","year":"1981","journal-title":"Science"},{"key":"10.1016\/j.peptides.2017.06.009_bib0010","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.yhbeh.2006.06.019","article-title":"Role of corticotropin releasing factor in anxiety disorders: a translational research perspective","volume":"50","author":"Risbrough","year":"2006","journal-title":"Horm. Behav."},{"key":"10.1016\/j.peptides.2017.06.009_bib0015","doi-asserted-by":"crossref","first-page":"383","DOI":"10.31887\/DCNS.2006.8.4\/ssmith","article-title":"The role of the hypothalamic-pituitary-adrenal axis in neuroendocrine responses to stress","volume":"8","author":"Smith","year":"2006","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.peptides.2017.06.009_bib0020","doi-asserted-by":"crossref","first-page":"485","DOI":"10.2174\/187152706778559336","article-title":"The hypothalamic-pituitary-adrenal axis: what can it tell us about stressors","volume":"5","author":"Armario","year":"2006","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.peptides.2017.06.009_bib0025","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0022-3956(98)90056-5","article-title":"The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety","volume":"33","author":"Holsboer","year":"1999","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.peptides.2017.06.009_bib0030","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1126\/science.6334362","article-title":"Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients","volume":"226","author":"Nemeroff","year":"1984","journal-title":"Science"},{"key":"10.1016\/j.peptides.2017.06.009_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0163-7258(98)00041-2","article-title":"Is there a future for neuropeptide receptor ligands in the treatment of anxiety disorders","volume":"82","author":"Griebel","year":"1999","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.peptides.2017.06.009_bib0040","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1210\/er.2005-0034","article-title":"The molecular mechanisms underlying the regulation of the biological activity of corticotropin-releasing hormone receptors: implications for physiology and pathophysiology","volume":"27","author":"Hillhouse","year":"2006","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.peptides.2017.06.009_bib0045","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/1096-9861(20001211)428:2<191::AID-CNE1>3.0.CO;2-U","article-title":"Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse","volume":"428","author":"Van Pett","year":"2000","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.peptides.2017.06.009_bib0050","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.peptides.2012.07.028","article-title":"Expression of corticotropin releasing factor receptor type 1 (CRF1) in the human gastrointestinal tract and upregulation in the colonic mucosa in patients with ulcerative colitis","volume":"38","author":"Yuan","year":"2012","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2017.06.009_bib0055","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1146\/annurev.pharmtox.44.101802.121410","article-title":"CRF and CRF receptors: role in stress responsivity and other behaviors","volume":"44","author":"Bale","year":"2004","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.peptides.2017.06.009_bib0060","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2174\/187152706777950684","article-title":"Corticotropin releasing factor (CRF) receptor signaling in the central nervous system: new molecular targets","volume":"5","author":"Hauger","year":"2006","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.peptides.2017.06.009_bib0065","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1038\/nn1123","article-title":"Limbic corticotropin-releasing hormone receptor 1 mediates anxiety-related behavior and hormonal adaptation to stress","volume":"6","author":"Muller","year":"2003","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.peptides.2017.06.009_bib0070","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S0896-6273(00)80491-2","article-title":"Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development","volume":"20","author":"Smith","year":"1998","journal-title":"Neuron"},{"key":"10.1016\/j.peptides.2017.06.009_bib0075","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/520","article-title":"Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1","volume":"19","author":"Timpl","year":"1998","journal-title":"Nat. Genet."},{"key":"10.1016\/j.peptides.2017.06.009_bib0080","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/S0022-3565(24)38220-5","article-title":"Receptor binding, behavioral, and electrophysiological profiles of nonpeptide corticotropin-releasing factor subtype 1 receptor antagonists CRA1000 and CRA1001","volume":"289","author":"Okuyama","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.peptides.2017.06.009_bib0085","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0893-133X(02)00299-3","article-title":"Brain penetrance, receptor occupancy and antistress in vivo efficacy of a small molecule corticotropin releasing factor type I receptor selective antagonist","volume":"27","author":"Heinrichs","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.peptides.2017.06.009_bib0090","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1126\/science.1069836","article-title":"Enhanced and delayed stress-induced alcohol drinking in mice lacking functional CRH1 receptors","volume":"296","author":"Sillaber","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.peptides.2017.06.009_bib0095","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1038\/sj.npp.1301328","article-title":"High-affinity CRF1 receptor antagonist NBI-34041: preclinical and clinical data suggest safety and efficacy in attenuating elevated stress response","volume":"32","author":"Ising","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.peptides.2017.06.009_bib0100","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1124\/jpet.102.042788","article-title":"The corticotropin-releasing factor1 receptor antagonist R121919 attenuates the behavioral and endocrine responses to stress","volume":"304","author":"Gutman","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.peptides.2017.06.009_bib0105","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.pbb.2009.03.015","article-title":"Transient forebrain over-expression of CRF induces plasma corticosterone and mild behavioural changes in adult conditional CRF transgenic mice","volume":"93","author":"Vicentini","year":"2009","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.peptides.2017.06.009_bib0110","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s10571-011-9784-0","article-title":"Assessing behavioural effects of chronic HPA axis activation using conditional CRH-overexpressing mice","volume":"32","author":"Dedic","year":"2012","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.peptides.2017.06.009_bib0115","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.pbb.2012.05.013","article-title":"The CRF(1) receptor antagonist SSR 125543 attenuates long-term cognitive deficit induced by acute inescapable stress in mice, independently from the hypothalamic pituitary adrenal axis","volume":"102","author":"Philbert","year":"2012","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.peptides.2017.06.009_bib0120","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Pxinos","year":"1998"},{"key":"10.1016\/j.peptides.2017.06.009_bib0125","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/0006-8993(93)90199-W","article-title":"Intracerebroventricular administration of corticotropin-releasing factor induces c-fos mRNA expression in brain regions related to stress responses: comparison with pattern of c-fos mRNA induction after stress","volume":"616","author":"Imaki","year":"1993","journal-title":"Brain Res."},{"key":"10.1016\/j.peptides.2017.06.009_bib0130","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.neuroscience.2003.12.024","article-title":"Gender-dependent alterations in corticosteroid receptor status and spatial performance following 21days of restraint stress","volume":"125","author":"Kitraki","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.peptides.2017.06.009_bib0135","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0143-4179(89)90085-1","article-title":"The effects of intracerebroventricularly injected corticotropin-releasing factor (CRF) on the central nervous system: behavioural and biochemical studies","volume":"13","author":"Matsuzaki","year":"1989","journal-title":"Neuropeptides"},{"key":"10.1016\/j.peptides.2017.06.009_bib0140","first-page":"189","article-title":"Designing new treatments for depression and anxiety","volume":"11","author":"Chen","year":"2008","journal-title":"IDrugs"},{"key":"10.1016\/j.peptides.2017.06.009_bib0145","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/da.20695","article-title":"Multicenter, randomized, double-blind, active comparator and placebo-controlled trial of a corticotropin-releasing factor receptor-1 antagonist in generalized anxiety disorder","volume":"27","author":"Coric","year":"2010","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.peptides.2017.06.009_bib0150","doi-asserted-by":"crossref","first-page":"515874","DOI":"10.1155\/2012\/515874","article-title":"A synthesis of the evidence for managing stress at work: a review of the reviews reporting on anxiety, depression, and absenteeism","volume":"2012","author":"Bhui","year":"2012","journal-title":"J. Environ. Public Health"},{"key":"10.1016\/j.peptides.2017.06.009_bib0155","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/297331a0","article-title":"Corticotropin releasing factor produces behavioural activation in rats","volume":"297","author":"Sutton","year":"1982","journal-title":"Nature"},{"key":"10.1016\/j.peptides.2017.06.009_bib0160","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/0196-9781(85)90323-7","article-title":"Effects of corticotropin releasing factor on locomotor activity in hypophysectomized rats","volume":"6","author":"Eaves","year":"1985","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2017.06.009_bib0165","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1177\/026988119300700406","article-title":"The effects of CRF and alpha-helical CRF on anxiety in normal and hypophysectomized rats","volume":"7","author":"Adamec","year":"1993","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.peptides.2017.06.009_bib0170","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.neuropharm.2010.09.015","article-title":"Endocrine and behavioural responses to acute central CRF challenge are antagonized in the periphery and CNS, respectively, in C57BL\/6 mice","volume":"60","author":"Pryce","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.peptides.2017.06.009_bib0175","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.pbb.2003.12.010","article-title":"Differential regulation of behavioral, genomic, and neuroendocrine responses by CRF infusions in rats","volume":"77","author":"Campbell","year":"2004","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.peptides.2017.06.009_bib0180","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1210\/endo.135.2.8033811","article-title":"Intracerebroventricular injection of corticotropin-releasing hormone in the pig: acute effects on behavior, adrenocorticotropin secretion, and immune suppression","volume":"135","author":"Johnson","year":"1994","journal-title":"Endocrinology"},{"key":"10.1016\/j.peptides.2017.06.009_bib0185","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1159\/000126974","article-title":"Unidirectional specific and modulated brain to blood transport of corticotropin-releasing hormone","volume":"63","author":"Martins","year":"1996","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.peptides.2017.06.009_bib0190","doi-asserted-by":"crossref","first-page":"10477","DOI":"10.1073\/pnas.93.19.10477","article-title":"CP-154,526: a potent and selective nonpeptide antagonist of corticotropin releasing factor receptors","volume":"93","author":"Schulz","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.peptides.2017.06.009_bib0195","first-page":"E312","article-title":"Acute modulation of active carrier-mediated brain-to-blood transport of corticotropin-releasing hormone","volume":"272","author":"Martins","year":"1997","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.peptides.2017.06.009_bib0200","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1159\/000059433","article-title":"Differential interactions of urocortin\/corticotropin-releasing hormone peptides with the blood-brain barrier","volume":"75","author":"Kastin","year":"2002","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.peptides.2017.06.009_bib0205","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1124\/jpet.102.038497","article-title":"Corticotropin-releasing hormone and brain mast cells regulate blood-brain-barrier permeability induced by acute stress","volume":"303","author":"Esposito","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.peptides.2017.06.009_bib0210","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1210\/en.2009-1039","article-title":"Corticotropin-releasing hormone receptor-1 in cerebral microvessels changes during development and influences urocortin transport across the blood-brain barrier","volume":"151","author":"Hsuchou","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.peptides.2017.06.009_bib0215","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1002\/dneu.20345","article-title":"Differential effects of stress and amphetamine administration on Fos-like protein expression in corticotropin releasing factor-neurons of the rat brain","volume":"67","author":"Rotllant","year":"2007","journal-title":"Dev. Neurobiol."},{"key":"10.1016\/j.peptides.2017.06.009_bib0220","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1126\/science.3131879","article-title":"Expression of c-fos protein in brain: metabolic mapping at the cellular level","volume":"240","author":"Sagar","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.peptides.2017.06.009_bib0225","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/jnr.22737","article-title":"Sex-dependent and differential responses to acute restraint stress of corticotropin-releasing factor-producing neurons in the rat paraventricular nucleus, central amygdala, and bed nucleus of the stria terminalis","volume":"90","author":"Sterrenburg","year":"2012","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.peptides.2017.06.009_bib0230","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1016\/j.peptides.2011.09.016","article-title":"Corticotropin-releasing factor (CRF) receptor subtypes in mediating neuronal activation of brain areas involved in responses to intracerebroventricular CRF and stress in rats","volume":"32","author":"Takahashi","year":"2011","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2017.06.009_bib0235","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ejphar.2003.11.032","article-title":"Anxiolytic- and antidepressant-like profile of a new CRF1 receptor antagonist, R278995\/CRA0450","volume":"485","author":"Chaki","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.peptides.2017.06.009_bib0240","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S0893-133X(01)00244-5","article-title":"Anxiolytic properties of the selective, non-peptidergic CRF(1) antagonists, CP154,526 and DMP695: a comparison to other classes of anxiolytic agent","volume":"25","author":"Millan","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.peptides.2017.06.009_bib0245","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0022-3956(00)00016-9","article-title":"Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: the first 20 patients treated","volume":"34","author":"Zobel","year":"2000","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.peptides.2017.06.009_bib0250","doi-asserted-by":"crossref","first-page":"4029","DOI":"10.1016\/j.bmc.2006.02.019","article-title":"Synthesis and in vivo evaluation of [11C]SN003 as a PET ligand for CRF1 receptors","volume":"14","author":"Kumar","year":"2006","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.peptides.2017.06.009_bib0255","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0969-8051(00)00199-2","article-title":"Synthesis and characterization of fluorinated and iodinated pyrrolopyrimidines as PET\/SPECT ligands for the CRF1 receptor","volume":"28","author":"Martarello","year":"2001","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.peptides.2017.06.009_bib0260","doi-asserted-by":"crossref","first-page":"4286","DOI":"10.1016\/j.bmc.2015.06.036","article-title":"Synthesis, F-18 radiolabeling, and microPET evaluation of 3-(2,4-dichlorophenyl)-N-alkyl-N-fluoroalkyl-2,5-dimethylpyrazolo[1,5-a]pyrimidin \u22127-amines as ligands of the corticotropin-releasing factor type-1 (CRF1) receptor","volume":"23","author":"Stehouwer","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.peptides.2017.06.009_bib0265","doi-asserted-by":"crossref","first-page":"5111","DOI":"10.1016\/j.bmcl.2015.10.010","volume":"25","author":"Stehouwer","year":"2015","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.peptides.2017.06.009_bib0270","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s00213-009-1714-1","article-title":"Dose-dependent effects of the CRF(1) receptor antagonist R317573 on regional brain activity in healthy male subjects","volume":"208","author":"Schmidt","year":"2010","journal-title":"Psychopharmacology (Berl)"}],"container-title":["Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978117302206?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978117302206?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T12:54:02Z","timestamp":1750510442000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196978117302206"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":54,"alternative-id":["S0196978117302206"],"URL":"https:\/\/doi.org\/10.1016\/j.peptides.2017.06.009","relation":{},"ISSN":["0196-9781"],"issn-type":[{"value":"0196-9781","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization of CRF1 receptor antagonists with differential peripheral vs central actions in CRF challenge in rats","name":"articletitle","label":"Article Title"},{"value":"Peptides","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.peptides.2017.06.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}